SMAD2 and neoplasm: Interestingly, megalin mRNA and protein levels were found to decrease in kidney and gallbladder epithelial cell lines upon in vitro activation of transforming growth factor-beta (TGF-ß1)—SMAD2/3 signaling pathway [63], which is well known for its tumor-suppressive effect [64].